Skip to content
777 Sourcing.

Capability

tumor-specific targeting moieties

Suppliers
1
States & provinces
1
Countries
1

1 tumor-specific targeting moieties supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BIFORMYX BIOPHARMA INC.

BOCA RATON, FL

BiFormyx BioPharma is a biopharma company developing dual-payload antibody-drug conjugates (DualADCs) to treat aggressive solid tumors such as TNBC with precision and potency. Its DualADC platform delivers two distinct therapeutic payloads (e.g., cytotoxic and immunomodulatory) directly to cancer cells using proprietary linker combinations and tumor-specific targeting moieties.

antibody-drug conjugate developmentproprietary linker combinations

Compiled from public sources

Related capabilities

Other processes offered by the shops that list tumor-specific targeting moieties.

Browse all capabilities